Topics

Cancer Therapies Stock News Bites: ImmunoGen (NASDAQ: $IMGN) Reports Recent Progress and 2019 Financial Results

09:30 EST 14 Feb 2020 | InvestorIdeas

February 14, 2020 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Cancer Therapies Stock News Bites- WALTHAM, Mass - ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter and year ended December 31, 2019.

Original Article: Cancer Therapies Stock News Bites: ImmunoGen (NASDAQ: $IMGN) Reports Recent Progress and 2019 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Cancer Therapies Stock News Bites: ImmunoGen (NASDAQ: $IMGN) Reports Recent Progress and 2019 Financial Results"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...